EQUITY PURCHASE AGREEMENT by and among ADIAL PHARMACEUTICALS, INC., PURNOVATE, LLC, THE MEMBERS OF PURNOVATE, LLC, AND ROBERT D. THOMPSON, AS THE MEMBERS’ REPRESENTATIVE Dated: December 7, 2020Equity Purchase Agreement • December 10th, 2020 • Adial Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS EQUITY PURCHASE AGREEMENT is made and entered into as of December 7, 2020, by and among Adial Pharmaceuticals, Inc., a Delaware corporation (the “Purchaser”), Purnovate, LLC, a Virginia limited liability company and any successor thereto (the “Company” or “Purnovate”)), each of the participating members of the Company set forth on the signature pages to this Agreement and each of the members of the Company who has delivered a Joinder Agreement in the form attached hereto as EXHIBIT B (the “Joinder Agreement”) agreeing to be bound by the terms of this Agreement (collectively, the “Members” and each, individually, a “Member”) and Robert D. Thompson, as representative of the Members pursuant to ARTICLE XI (the “Members’ Representative”).
